# FDA Inspection 1026925 - Vitalant - August 22, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/113e155d-4382-4a82-9d01-3fff21e7e358
Source feed: FDA_Inspections

> FDA Inspection 1026925 for Vitalant on August 22, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026925
- Company Name: Vitalant
- Inspection Date: 2017-08-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1312762 - 2026-04-01](https://www.keypedia.com/records/fda_inspections/vitalant/22af54a8-960f-4d8e-ba76-de872a2003a2)
- [FDA Inspection 1312762 - 2026-04-01](https://www.keypedia.com/records/fda_inspections/vitalant/641930a6-f4d1-43a7-bf3d-4d943dbac88b)
- [FDA Inspection 1122872 - 2020-03-04](https://www.keypedia.com/records/fda_inspections/vitalant/8c116171-a34a-4ef9-9e39-7666f3d781d6)
- [FDA Inspection 1122872 - 2020-03-04](https://www.keypedia.com/records/fda_inspections/vitalant/bf864bd5-86a9-48cf-b332-57f154b3f178)
- [FDA Inspection 1018497 - 2017-07-19](https://www.keypedia.com/records/fda_inspections/vitalant/a52b66f1-5fe6-48a0-9726-dbd9ec9ce988)

Company: https://www.keypedia.com/companies/vitalant/71419872-ea41-4a31-a9c5-4caa170b1b73

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d